ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

18β-glycyrrhetinic acid regulates mitochondrial ribosomal protein L35-associated apoptosis signaling pathways to inhibit proliferation of gastric carcinoma cells

Yuan, Ling; Yang, Yi; Li, Xia; Zhou, Xin; Du, Yu-Hua; Liu, Wen-Jing; Zhang, Lei; Yu, Lei; Ma, Ting-Ting; Li, Jia-Xin; Chen, Yan; Nan, Yi*哈尔滨医科大学; y
WORLD JOURNAL OF GASTROENTEROLOGY2022-6-14DOI: 10.3748/wjg.v28.i22.2437
6被引9阅读
引用收藏
分享

摘要

BACKGROUND Gastric carcinoma (GC) is a common gastrointestinal malignancy worldwide. Based on the cancer-related mortality, the current prevention and treatment strategies for GC still show poor clinical results. Therefore, it is important to find effective drug treatment targets. AIM To explore the mechanism by which 18 beta-glycyrrhetinic acid (18 beta-GRA) regulates mitochondrial ribosomal protein L35 (MRPL35) related signal proteins to inhibit the proliferation of GC cells. METHODS Cell counting kit-8 assay was used to detect the effects of 18 beta-GRA on the survival rate of human normal gastric mucosal cell line GES-1 and the proliferation of GC cell lines MGC80-3 and BGC-823. The apoptosis and cell cycle were assessed by flow cytometry. Cell invasion and migration were evaluated by Transwell assay, and cell scratch test was used to detect cell migration. Furthermore, a tumor model was established by hypodermic injection of 2.5 x 106 BGC-823 cells at the selected positions of BALB/c nude mice to determine the effect of 18 beta-GRA on GC cell proliferation, and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to detect MRPL35 expression in the engrafted tumors in mice. We used the term tandem mass tag (TMT) labeling combined with liquid chromatography-tandem mass spectrometry to screen for differentially expressed proteins (DEPs) extracted from GC cells and control cells after 18 beta-GRA intervention. A detailed bioinformatics analysis of these DEPs was performed, including Gene Ontology annotation and enrichment analysis, Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis, and so on. Moreover, STRING database (https://string-db.org/) was used to predict proteinprotein interaction (PPI) relationships and Western blot was used to detect the expression of proteins of interest in GC cells. RESULTS The results indicated that 18 ss-GRA could inhibit the proliferation of GC cells in a dose- and timedependent manner. It could induce GC cell apoptosis and arrest the cell cycle at G0/G1 phase. The proportion of cells arrested at S phase decreased with the increase of 18-GRA dose, and the migration and invasiveness of GC cells were inhibited. The results of animal experiments showed that 18 beta-GRA could inhibit tumor formation in BALB/c nude mice, and qRT-PCR results showed that MRPL35 expression level was significantly reduced in the engrafted tumors in mice. Using TMT technology, 609 DEPs, among which 335 were up-regulated and 274 were down-regulated, were identified in 18 beta-GRA intervention compared with control. We found that the intervention of 18 beta-GRA in GC cells involved many important biological processes and signaling pathways, such as cellular processes, biological regulation, and TP53 signaling pathway. Notably, after the drug intervention, MRPL35 expression was significantly down- regulated (P = 0.000247), TP53 expression was up-regulated (P = 0.02676), and BCL2L1 was down- regulated (P = 0.01699). Combined with the Retrieval of Interacting Genes/Proteins database, we analyzed the relationship between MRPL35, TP53, and BCL2L1 signaling proteins, and we found that COPS5, BAX, and BAD proteins can form a PPI network with MRPL35, TP53, and BCL2L1. Western blot analysis confirmed the intervention effect of 18 beta-GRA on GC cells, MRPL35, TP53, and BCL2L1 showed dose-dependent up/down- regulation, and the expression of COPS5, BAX, and BAD also increased/decreased with the change of 18 beta-GRA concentration. @@@ CONCLUSION 18 beta-GRA can inhibit the proliferation of GC cells by regulating MRPL35, COPS5, TP53, BCL2L1, BAX, and BAD.

学科与关键词

关键词
Gastric carcinoma18 beta-glycyrrhetinic acidMitochondrial ribosomal protein L35ProliferationInvasionApoptosis
相关
加载中…
  • Evaluation of the Anticancer Activity and Mechanism Studies of Glycyrrhetic Acid Derivatives toward HeLa Cells
    Chen, Ju; Xu, Yunran; Yang, Yan*; Yao, Xin; Fu, Yuan; Wang, Yi; Liu, Yunjun; Wang, Xiuzhen*MOLECULES, 2023, 28(7): 3164.被引 3
  • Antitumor activity of miR-188-3p in gastric cancer is achieved by targeting CBL expression and inactivating the AKT/mTOR signaling
    Lin, Jian-Jiao; Luo, Bao-Hua; Su, Tao; Yang, Qiong; Zhang, Qin-Fei; Dai, Wei-Yu; Liu, Yan; Xiang, Li*World Journal of Gastrointestinal Oncology, 2023, 15(8): 1384-1399.被引 1
  • Oridonin suppresses gastric cancer SGC-7901 cell proliferation by targeting the TNF-alpha/androgen receptor/TGF-beta signalling pathway axis
    Gao, Shiyong*; Tan, Huixin*; Li, DanJournal of Cellular and Molecular Medicine, 2023.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
WORLD JOURNAL OF GASTROENTEROLOGY
发表日期
2022-06-14
卷期
第 28 卷, 第 22 期
页码
2437-2456
DOI
10.3748/wjg.v28.i22.2437
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
Ningxia Natural Science Foundation [2020AAC03130]; Ningxia Medical University Project [XM2020005]

作者

  • Y

    Yuan, Ling (第一作者)

    ningxia med univ

  • Y

    Yang, Yi

    ningxia med univ

查看全部 12 位作者收起作者
  • L

    Li, Xia

    ningxia med univ

  • Z

    Zhou, Xin

    ningxia med univ

  • D

    Du, Yu-Hua

    ningxia med univ

  • L

    Liu, Wen-Jing

    ningxia med univ

  • Z

    Zhang, Lei

    ningxia med univ

  • Y

    Yu, Lei

    harbin med univ

  • M

    Ma, Ting-Ting

    ningxia med univ

  • L

    Li, Jia-Xin

    ningxia med univ

  • C

    Chen, Yan

    ningxia med univ

  • N

    Nan, Yi (通讯)

    ningxia med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417